Camp4 Therapeutics Corporation (CAMP)
NASDAQ: CAMP · Real-Time Price · USD
3.220
-0.080 (-2.42%)
Oct 26, 2026, 1:48 PM EDT - Market open
Camp4 Therapeutics Revenue
Camp4 Therapeutics had revenue of $1.78M in the quarter ending June 30, 2026, with 18.84% growth. This brings the company's total for the last twelve months to $4.22M, up 40.21% year-over-year. In the year 2025, Camp4 Therapeutics had annual revenue of $3.50M with 436.50% growth. That makes Camp4 Therapeutics the 40,532nd largest company in the world by revenue and 5,406th in the United States.
Revenue (ttm)
$4.22M
Revenue Growth
+40.21%
P/S Ratio
47.93
Revenue / Employee
$87,833
Employees
48
Market Cap
202.07M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 3.50M | 2.85M | 436.50% |
| Dec 31, 2024 | 652.00K | 302.00K | 86.29% |
| Dec 31, 2023 | 350.00K | - | - |
| Dec 31, 2022 | - | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
CAMP News
- 3 days ago - Camp4 Therapeutics initiated with a Strong Buy at Raymond James - TheFly
- 6 days ago - Camp4 Therapeutics Transcript: Chardan's 10th Annual Healthcare Conference - Transcripts
- 11 days ago - Camp4 Therapeutics initiated with a Buy at Needham - TheFly
- 12 days ago - CAMP4 to Participate in Chardan's 10th Annual Healthcare Conference - GlobeNewsWire
- 21 days ago - Camp4 Therapeutics initiated with an Outperform at Oppenheimer - TheFly
- 27 days ago - Camp4 Therapeutics price target lowered to $6 from $6.50 at Chardan - TheFly
- 4 weeks ago - Camp4 Therapeutics Transcript: Analyst Day 2026 - Transcripts
- 4 weeks ago - Camp4 Therapeutics Slides: FY 2026 - Filings